Homepage

4Cell Therapies S.A. is developing CAR-T technology in Poland for cancer treatment, based on patented solutions. Research and development efforts are conducted in Warsaw and Gliwice by Polish scientists with international experience.

  • Expert Scientific Team
  • Collaboration with Leading Institutions
  • Dedication to Patients
  • Investment in Modern Technologies
  • Ethics and Social Responsibility
  • Active Clinical Research
  • Leader in Biotechnology Innovation
  • Transparency and Trust
01

CAR-T Therapies for Solid Tumors

4Cell Therapies is developing CAR-T treatments targeting solid tumors, including the challenging pancreatic cancer. Through advanced genetic engineering, we create antigen receptors that precisely identify and destroy cancer cells. Preclinical studies confirm the high efficacy of our therapies and their potential to reduce side effects.
02

CAR-T Therapies for Hematologic Cancers

We offer new treatment options for blood cancers, such as leukemia and lymphoma, using CAR-T therapies. Advanced T-cell genetic modification technology allows precise targeting of cancer cells, demonstrating significant potential and high effectiveness in laboratory and animal models.
03

Innovative Production Solutions

We optimize CAR-T production processes, implementing advanced automation and meeting GMP (Good Manufacturing Practice) standards. Our innovative solutions enable production scalability, essential for future commercialization.
04

Safety and Scientific Excellence

We conduct research following the highest scientific standards. Extensive preclinical studies allow for a thorough assessment of the efficacy and safety of our therapies, testing on advanced animal models and laboratory conditions to detect and eliminate potential risks before clinical trials.

Discover our development directions

Research and Development

We conduct advanced projects in CAR-T therapies, focusing on innovative solutions for treating solid and hematologic cancers. Our team of internationally experienced scientists continuously works on developing effective and safe therapies that will transform oncology.

Learn more →

Research Services

We offer specialized research services for real-time cell viability analysis. Using state-of-the-art equipment and methodologies, we support biotech and pharmaceutical companies, as well as research institutions, in conducting comprehensive studies on new substances and therapies.

Explore our offer →

Investment Collaboration

We invite investors to join the rapidly growing CAR-T therapy market. We offer a unique opportunity to support groundbreaking biotech projects with the potential to significantly impact the future of medicine. Discover how you can be part of the revolution in cancer treatment.

Invest with us →

Investment Process at 4Cell Therapies

Contact the Investment Department

Reach out for detailed information on current investment opportunities.

Sign the Investment Agreement

After reviewing the offer, the investor signs the agreement and makes a capital contribution.

Continuous Contact and Updates

Investors have access to regular company updates, financial reports, and shareholder meetings.

Aktualności